ArticleJournal for immunotherapy of cancer2020

Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B.

Ana Alvarez de Cienfuegos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.